Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ideal oral combinations to eradicate HCV: The role of ribavirin.

Journal of hepatology - 1 Jan 2016

Hézode Christophe, Bronowicki Jean-Pierre

Abstract excerpt

Current all-oral interferon-free regimens offer sustained virological response (SVR) rates above 90% as well as 12-week treatment durations for the majority of patients with chronic hepatitis C virus (HCV), including treatment-naïve and -experienced patients with or without cirrhosis. There are multiple direct-acting antiviral (DAA) combinations that can be selected to optimize efficacy and safety outcomes. Each...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbamates
Share to Cyclopropanes
Share to Fluorenes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lactams, Macrocyclic

Share to Macrocyclic Compounds

Share to Pyrrolidines

Share to Simeprevir

Share to Sofosbuvir

Source

Identifiers

PMID: 26409316
DOI: 10.1016/j.jhep.2015.09.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ideal oral combinations to eradicate HCV: The role of ribavirin.PMID 26409316Read ↗

Role of ribavirin in interferon-free therapy for the treatment of hepatitisC virus.Semantic proximity Read ↗

New hepatitis C therapies: the toolbox, strategies, and challenges.Semantic proximity Read ↗

Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection.Semantic proximity Read ↗

Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review.Semantic proximity Read ↗

Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?Semantic proximity Read ↗

The hepatitis C revolution part 1: antiviral treatment options.Semantic proximity Read ↗

Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.Semantic proximity Read ↗

Optimal IFN-free therapy in treatment-naïve patients with HCV genotype 1 infection.Semantic proximity Read ↗

Ribavirin in the treatment of hepatitis C.Semantic proximity Read ↗

A review of standard and newer treatment strategies in hepatitis C.Semantic proximity Read ↗

The current treatment of Hepatitis C.Semantic proximity Read ↗

Ombitasvir and paritaprevir boosted with ritonavir and combined with dasabuvir for chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.